Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP.

Corneli A, Wang M, Agot K, Ahmed K, Lombaard J, Van Damme L; FEM-PrEP Study Group.

J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):555-63. doi: 10.1097/QAI.0000000000000362.

PMID:
25393942
2.

A descriptive analysis of perceptions of HIV risk and worry about acquiring HIV among FEM-PrEP participants who seroconverted in Bondo, Kenya, and Pretoria, South Africa.

Corneli AL, McKenna K, Headley J, Ahmed K, Odhiambo J, Skhosana J, Wang M, Agot K; FEM-PrEP Study Group.

J Int AIDS Soc. 2014 Sep 8;17(3 Suppl 2):19152. doi: 10.7448/IAS.17.3.19152. eCollection 2014.

3.

FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis.

Corneli AL, Deese J, Wang M, Taylor D, Ahmed K, Agot K, Lombaard J, Manongi R, Kapiga S, Kashuba A, Van Damme L; FEM-PrEP Study Group.

J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):324-31. doi: 10.1097/QAI.0000000000000158.

4.

Preexposure prophylaxis for HIV infection among African women.

Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, Malahleha M, Owino F, Manongi R, Onyango J, Temu L, Monedi MC, Mak'Oketch P, Makanda M, Reblin I, Makatu SE, Saylor L, Kiernan H, Kirkendale S, Wong C, Grant R, Kashuba A, Nanda K, Mandala J, Fransen K, Deese J, Crucitti T, Mastro TD, Taylor D; FEM-PrEP Study Group.

N Engl J Med. 2012 Aug 2;367(5):411-22. doi: 10.1056/NEJMoa1202614. Epub 2012 Jul 11.

5.

Microbiological studies of an anaerobic baffled reactor: microbial community characterisation and deactivation of health-related indicator bacteria.

Lalbahadur T, Pillay S, Rodda N, Smith M, Buckley C, Holder F, Bux F, Foxon K.

Water Sci Technol. 2005;51(10):155-62.

PMID:
16104417

Supplemental Content

Loading ...
Support Center